Aromatase inhibitor use is a risk factor of carotid plaque presence in endocrine-responsive breast cancer patients.
about
Aromatase inhibitor use is a risk factor of carotid plaque presence in endocrine-responsive breast cancer patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Aromatase inhibitor use is a r ...... onsive breast cancer patients.
@en
Aromatase inhibitor use is a r ...... onsive breast cancer patients.
@nl
type
label
Aromatase inhibitor use is a r ...... onsive breast cancer patients.
@en
Aromatase inhibitor use is a r ...... onsive breast cancer patients.
@nl
prefLabel
Aromatase inhibitor use is a r ...... onsive breast cancer patients.
@en
Aromatase inhibitor use is a r ...... onsive breast cancer patients.
@nl
P2093
P356
P1476
Aromatase inhibitor use is a r ...... onsive breast cancer patients.
@en
P2093
Byeong Woo Park
Da Hea Seo
Seung-Il Kim
P304
P356
10.3904/KJIM.2016.205
P577
2017-08-25T00:00:00Z